Human Leukocyte Antigens (HLA) Genes Association in Type 1 Diabetic Nephropathy

Diabetic nephropathy is a common worldwide multifactorial disease where involvement of genetic factors is well etablished. The aim of this study was to investigate the HLA genes implication in the development of type 1 diabetic nephropathy. We performed a case- control study where one hundred and fi...

Full description

Saved in:
Bibliographic Details
Published inEndocrine, metabolic & immune disorders drug targets Vol. 19; no. 8; p. 1157
Main Authors Mihoubi, Esma, Amroun, Habiba, Raache, Rachida, Bouldjennet, Faiza, Meçabih, Fethi, Azzouz, Malha, Boudiba, Aissa, Mahgoun, Souad, Akachouche, Malika, Salhi, Nawel, Touil-Boukoffa, Chafia, Abbadi, Mohamed C, Attal, Nabila
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2019
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Diabetic nephropathy is a common worldwide multifactorial disease where involvement of genetic factors is well etablished. The aim of this study was to investigate the HLA genes implication in the development of type 1 diabetic nephropathy. We performed a case- control study where one hundred and fifty subjects were examined. Patients were divided in two groups; with and without type 1 diabetic nephropathy. HLA typing was performed using Polymerase Chain Reaction- Sequence Specific Oligonucleotide (PCR- SSO) method. HLA association to clinical phenotype and HLA haplotype analysis was also investigated. HLA B*51 is increased in patients without type 1 diabetic nephropathy (7.14% vs. 0 %, P <0.05, OR= 0), however no other studied alleles seem to have any effect (all P>0.05). Haplotype analysis also does not reveal any significant association, however, A*02-B*18-DRB1*03-DQA1*05- DQB1*03 haplotype shows a tendency to be associated with the development of diabetic nephropathy (P = 0.05). These results suggest a protective effect of HLA B*51 allele from type 1 diabetic nephropathy. However, further studies are required in order to clarify its potential implication as a protective marker.
ISSN:2212-3873
DOI:10.2174/1871530319666190215143059